Ticker
PRPHCompany Name
PROPHASE LABS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -19.15M | $ -0.46 | 1 | 41.54M |
3/31/2025 | $ -23.55M | $ -0.67 | 1 | 35.23M |
12/31/2024 | $ -36.17M | $ -1.77 | 1 | 20.46M |
9/30/2024 | $ -27.25M | $ -1.43 | 1 | 19.08M |
6/30/2024 | $ -26.43M | $ -1.4 | 1 | 18.89M |
3/31/2024 | $ -23.5M | $ -1.3 | 1 | 18.05M |
12/31/2023 | $ -14.83M | $ -0.86 | 1 | 17.21M |
9/30/2023 | $ -9.64M | $ -0.56 | 1 | 17.18M |
6/30/2023 | $ -1.69M | $ -0.1 | 1 | 16.84M |
3/31/2023 | $ 13.41M | $ 0.8 | 1 | 16.75M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for PROPHASE LABS INC is calculated as follows: EBITDA [ $ -1.26M ] / (Shares WA [ 11.6M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -0.11 ]
Minimum
Dec 31, 2024
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 3.78K |
---|---|
min | $ -11.29 |
max | $ 14.03 |
average | $ 2.03 |
median | $ 1 |
std | $ 4.28 |